Aortopathy Panel

Aortopathy Panel

Aortopathies are a group of complex, related disorders with overlapping phenotypes and genetic heterogeneity. They can be characterized by aneurysms, dilation, and tortuosity of the aorta that occur as a result of disruption to the genes involved in connective tissues and those related to the structure and function of the aortic wall.

Aortopathy can be treated using targeted therapy and/or appropriate interventional surgery, therefore an accurate genetic diagnosis is important. The NewGene Aortopathy panel includes 15 genes implicated in the following disorders:

  • Marfan syndrome
  • Loeys-Dietz syndrome type 1A and type 2A
  • Loeys-Dietz syndrome type 1B and type 2B
  • Loeys-Dietz syndrome type 1C also known as aneurysm-osteoarthritis syndrome
  • Ehlers-Danlos syndrome type IV, autosomal dominant
  • Thoracic aortic aneurysms and aortic dissections/aortic aneurysm, familial thoracic TAAD/AAT
  • Arthrogryposis, distal, type 9/contractural arachnodactyly, congenital
  • Arterial tortuosity syndrome
  • Aortic valve disease-1
  • X-linked cardiac valvular dysplasia.

Contact us

NewGene Limited
Bioscience Building
International Centre for Life
Newcastle upon Tyne
NE1 4EP, UK

Tel: +44 (0)191 242 1923
Fax: +44 (0)191 241 8799
Email: info@newgene.org.uk

Click here for location map

Mon – Fri 08:30 to 17:00, closed Bank Holidays

An ISO 15189 accredited Medical Laboratory company

NewGene Limited | Company Number: 06735445

Technology Partners

Agilent Technologies

Agena Bioscience

Illumina

Sophia Genetics

Qiagen

Promega

Enquiry form